The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income (loss) | 2,842 |
| Provision for credit losses - loans | 736 |
| Provision (credit) for credit losses - off-balance sheet credit exposures | 95 |
| Net (accretion) amortization of securities | 149 |
| Depreciation and amortization | 593 |
| Net realized gain on sales of securities available for sale | 117 |
| Net unrealized gain on discontinued financial derivative | -463 |
| Stock dividends on restricted investments | 155 |
| Net increase on other investment | 157 |
| Appreciation on bank-owned life insurance | 173 |
| Esop compensation expense for allocated shares | 253 |
| Loss (gain) on sale other real estate owned | -19 |
| Fair value adjustment on other real estate owned | 495 |
| Stock-based compensation | 607 |
| Deferred income tax expense (benefit) | 405 |
| Loss on fair value adjustment of fair value hedges | -10 |
| Accrued interest receivable | -31 |
| Other assets | 229 |
| Accrued expenses and other liabilities | -3,212 |
| Net cash from operating activities | 1,367 |
| Net change in interest bearing deposits in banks | 4,211 |
| Purchases | 53,718 |
| Sales | 23,797 |
| Available For Sale | 47,683 |
| Held To Maturity | 3,724 |
| Redemptions of restricted investments | 1,096 |
| Purchases of other investment | 169 |
| Loan originations and principal collections, net | 19,189 |
| Net decrease (increase) in net investment in direct financing leases | 73 |
| Proceeds from sales of other real estate owned | 568 |
| Additions of premises and equipment | 394 |
| Net cash from investing activities | 7,682 |
| Net (decrease) increase in deposits | -7,924 |
| Advances from fhlb and other borrowings | 16,052 |
| Payments on fhlb and other borrowings | 20,261 |
| Cash dividends declared and paid | 593 |
| Purchases of treasury stock | 3,163 |
| Net cash used for financing activities | -15,889 |
| Net change in cash and cash equivalents | -6,840 |
| Cash and cash equivalents at beginning of period | 13,290 |
| Cash and cash equivalents at end of period | 6,450 |